Grunenthal News and Activities

Grunenthal has a direct presence in 5 countries.

Grunenthal has 5 subsidiaries including Averitas Pharma, Grunenthal France and Grunenthal Italy.

They are in:

• Pharmaceuticals67%
• Biotechnology33%

View the org chart displaying its 43 main executives

Most searched biographies at Grunenthal

• Gabriel Baertschi, Chairman of the Executive Board and Chief Execu...
• Martin Zugel, Director
• Pär Johansson, Chairman of the Supervisory Board

Create your alert
to follow the executive moves at Grunenthal.

Grunenthal has 1,920 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).

Popular M&A news in Pharmaceuticals

• Vertex Pharmaceuticals has announced the acquisition of Crinetics Pharmaceuticals  (posted on July 7 2026).
• Novartis has announced the acquisition of Myricx Bio  (posted on July 6 2026).
• Ipsen has announced the acquisition of Kartos Therapeutics  (posted on July 3 2026).

Popular contacts in Pharmaceuticals

• David Ricks - President, Chief Executive Officer and Chairman of the Board at Eli Lilly
• Richard Saynor - Chief Executive Officer at Sandoz
• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson

Learn more about the Pharmaceuticals industry

Press releases by Grunenthal

• Stories | Media | Grünenthal Group
• Press Releases | Media | Grünenthal Group
• Media | Grünenthal Group
• Media | Grünenthal Group
• 2020 Press Releases | Media | Grünenthal Group
• Media | Grünenthal Group
• Media | Grünenthal Group
• View more press releases Close

Social media about Grunenthal

• Grunenthal on Wikipedia, Google News & Yahoo Finance
• Grunenthal on LinkedIn, X (Twitter) & YouTube